Gergana Zlateva
VP, Value & Access Strategy Business Unit Lead, Oncology, Patient & Health Impact, Pfizer Inc.
Gergana Zlateva is listed as VP, Value & Access Strategy Business Unit Lead, Oncology, Patient & Health Impact, Pfizer Inc.. Gergana is scheduled to speak at World Evidence, Pricing and Access Congress USA on 14 September 2027.
Compiled from published conference agendas; not yet confirmed by Gergana. Is this you? Claim this profile.
Upcoming
World Evidence, Pricing and Access Congress USA 14 September 2027 – 15 September 2027
Announced as a speaker.
Others from Pfizer Inc.
- Chang-ning Liu Lead of Animal Models and Imaging 2 sessions
- Claire Telford Senior Director, Value & Evidence Team Lead, Method’s Innovation 1 session
- Cody Robarts Senior Computational Toxicologist 1 session
- Edward I Broughton Senior Director, HEOR 1 session
- Eelko den Breejen Head of Oncology Portfolio & Market Engagement | Global Access, Strategy & Pricing. 1 session